BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 29656893)

  • 1. DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.
    Gupta R; Somyajit K; Narita T; Maskey E; Stanlie A; Kremer M; Typas D; Lammers M; Mailand N; Nussenzweig A; Lukas J; Choudhary C
    Cell; 2018 May; 173(4):972-988.e23. PubMed ID: 29656893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells.
    Dev H; Chiang TW; Lescale C; de Krijger I; Martin AG; Pilger D; Coates J; Sczaniecka-Clift M; Wei W; Ostermaier M; Herzog M; Lam J; Shea A; Demir M; Wu Q; Yang F; Fu B; Lai Z; Balmus G; Belotserkovskaya R; Serra V; O'Connor MJ; Bruna A; Beli P; Pellegrini L; Caldas C; Deriano L; Jacobs JJL; Galanty Y; Jackson SP
    Nat Cell Biol; 2018 Aug; 20(8):954-965. PubMed ID: 30022119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice.
    Findlay S; Heath J; Luo VM; Malina A; Morin T; Coulombe Y; Djerir B; Li Z; Samiei A; Simo-Cheyou E; Karam M; Bagci H; Rahat D; Grapton D; Lavoie EG; Dove C; Khaled H; Kuasne H; Mann KK; Klein KO; Greenwood CM; Tabach Y; Park M; Côté JF; Masson JY; Maréchal A; Orthwein A
    EMBO J; 2018 Sep; 37(18):. PubMed ID: 30154076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. REV7 counteracts DNA double-strand break resection and affects PARP inhibition.
    Xu G; Chapman JR; Brandsma I; Yuan J; Mistrik M; Bouwman P; Bartkova J; Gogola E; Warmerdam D; Barazas M; Jaspers JE; Watanabe K; Pieterse M; Kersbergen A; Sol W; Celie PHN; Schouten PC; van den Broek B; Salman A; Nieuwland M; de Rink I; de Ronde J; Jalink K; Boulton SJ; Chen J; van Gent DC; Bartek J; Jonkers J; Borst P; Rottenberg S
    Nature; 2015 May; 521(7553):541-544. PubMed ID: 25799992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 53BP1 cooperation with the REV7-shieldin complex underpins DNA structure-specific NHEJ.
    Ghezraoui H; Oliveira C; Becker JR; Bilham K; Moralli D; Anzilotti C; Fischer R; Deobagkar-Lele M; Sanchiz-Calvo M; Fueyo-Marcos E; Bonham S; Kessler BM; Rottenberg S; Cornall RJ; Green CM; Chapman JR
    Nature; 2018 Aug; 560(7716):122-127. PubMed ID: 30046110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The shieldin complex mediates 53BP1-dependent DNA repair.
    Noordermeer SM; Adam S; Setiaputra D; Barazas M; Pettitt SJ; Ling AK; Olivieri M; Álvarez-Quilón A; Moatti N; Zimmermann M; Annunziato S; Krastev DB; Song F; Brandsma I; Frankum J; Brough R; Sherker A; Landry S; Szilard RK; Munro MM; McEwan A; Goullet de Rugy T; Lin ZY; Hart T; Moffat J; Gingras AC; Martin A; van Attikum H; Jonkers J; Lord CJ; Rottenberg S; Durocher D
    Nature; 2018 Aug; 560(7716):117-121. PubMed ID: 30022168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An OB-fold complex controls the repair pathways for DNA double-strand breaks.
    Gao S; Feng S; Ning S; Liu J; Zhao H; Xu Y; Shang J; Li K; Li Q; Guo R; Xu D
    Nat Commun; 2018 Sep; 9(1):3925. PubMed ID: 30254264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAD2L2 controls DNA repair at telomeres and DNA breaks by inhibiting 5' end resection.
    Boersma V; Moatti N; Segura-Bayona S; Peuscher MH; van der Torre J; Wevers BA; Orthwein A; Durocher D; Jacobs JJL
    Nature; 2015 May; 521(7553):537-540. PubMed ID: 25799990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dystonia gene THAP1 controls DNA double-strand break repair choice.
    Shinoda K; Zong D; Callen E; Wu W; Dumitrache LC; Belinky F; Chari R; Wong N; Ishikawa M; Stanlie A; Multhaupt-Buell T; Sharma N; Ozelius L; Ehrlich M; McKinnon PJ; Nussenzweig A
    Mol Cell; 2021 Jun; 81(12):2611-2624.e10. PubMed ID: 33857404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H3K4 methylation by SETD1A/BOD1L facilitates RIF1-dependent NHEJ.
    Bayley R; Borel V; Moss RJ; Sweatman E; Ruis P; Ormrod A; Goula A; Mottram RMA; Stanage T; Hewitt G; Saponaro M; Stewart GS; Boulton SJ; Higgs MR
    Mol Cell; 2022 May; 82(10):1924-1939.e10. PubMed ID: 35439434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 53BP1-RIF1-shieldin counteracts DSB resection through CST- and Polα-dependent fill-in.
    Mirman Z; Lottersberger F; Takai H; Kibe T; Gong Y; Takai K; Bianchi A; Zimmermann M; Durocher D; de Lange T
    Nature; 2018 Aug; 560(7716):112-116. PubMed ID: 30022158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIF1 acts in DNA repair through phosphopeptide recognition of 53BP1.
    Setiaputra D; Escribano-Díaz C; Reinert JK; Sadana P; Zong D; Callen E; Sifri C; Seebacher J; Nussenzweig A; Thomä NH; Durocher D
    Mol Cell; 2022 Apr; 82(7):1359-1371.e9. PubMed ID: 35216668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 53BP1-shieldin-dependent DSB processing in BRCA1-deficient cells requires CST-Polα-primase fill-in synthesis.
    Mirman Z; Sasi NK; King A; Chapman JR; de Lange T
    Nat Cell Biol; 2022 Jan; 24(1):51-61. PubMed ID: 35027730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone chaperone ASF1 acts with RIF1 to promote DNA end joining in BRCA1-deficient cells.
    Tang M; Chen Z; Wang C; Feng X; Lee N; Huang M; Zhang H; Li S; Xiong Y; Chen J
    J Biol Chem; 2022 Jun; 298(6):101979. PubMed ID: 35472331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of DNA double-strand break repair pathway choice: a new focus on 53BP1.
    Zhang F; Gong Z
    J Zhejiang Univ Sci B; 2021 Jan; 22(1):38-46. PubMed ID: 33448186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ataxin-3 consolidates the MDC1-dependent DNA double-strand break response by counteracting the SUMO-targeted ubiquitin ligase RNF4.
    Pfeiffer A; Luijsterburg MS; Acs K; Wiegant WW; Helfricht A; Herzog LK; Minoia M; Böttcher C; Salomons FA; van Attikum H; Dantuma NP
    EMBO J; 2017 Apr; 36(8):1066-1083. PubMed ID: 28275011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An AlphaFold2 map of the 53BP1 pathway identifies a direct SHLD3-RIF1 interaction critical for shieldin activity.
    Sifri C; Hoeg L; Durocher D; Setiaputra D
    EMBO Rep; 2023 Aug; 24(8):e56834. PubMed ID: 37306046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic expression of RNF168 and 53BP1 increases mutagenic but not physiological non-homologous end joining.
    Zong D; Callén E; Pegoraro G; Lukas C; Lukas J; Nussenzweig A
    Nucleic Acids Res; 2015 May; 43(10):4950-61. PubMed ID: 25916843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 53BP1 Enforces Distinct Pre- and Post-resection Blocks on Homologous Recombination.
    Callen E; Zong D; Wu W; Wong N; Stanlie A; Ishikawa M; Pavani R; Dumitrache LC; Byrum AK; Mendez-Dorantes C; Martinez P; Canela A; Maman Y; Day A; Kruhlak MJ; Blasco MA; Stark JM; Mosammaparast N; McKinnon PJ; Nussenzweig A
    Mol Cell; 2020 Jan; 77(1):26-38.e7. PubMed ID: 31653568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASF1a Promotes Non-homologous End Joining Repair by Facilitating Phosphorylation of MDC1 by ATM at Double-Strand Breaks.
    Lee KY; Im JS; Shibata E; Dutta A
    Mol Cell; 2017 Oct; 68(1):61-75.e5. PubMed ID: 28943310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.